Company-Specific News: Positive or negative announcements regarding IMV's research, clinical trial results, or partnerships directly influence investor sentiment and stock price.

Overall Market Conditions: Broad market trends, economic health, and investor risk appetite impact almost all stocks, including IMV.F.

Industry Trends: Developments in the immunotherapy sector, competitive landscape, and regulatory changes affecting cancer treatments can shift investor perception of IMV's potential.

Financial Performance: IMV's cash position, burn rate, and ability to secure funding influence investor confidence in the company's long-term viability.

Investor Sentiment: Social media buzz, online forums, and overall market hype can drive short-term fluctuations in stock price, regardless of fundamental value.

Regulatory Approvals: Progress toward regulatory approval for IMV's products greatly impacts the company's perceived value and investor enthusiasm.

Competition: The success or failure of competing therapies and companies can affect the perceived value and market share potential of IMV.F.